Tolerance of polysomnography in children with neurodevelopmental disorders compared to neurotypical peers.


Journal

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977

Informations de publication

Date de publication:
01 09 2023
Historique:
pmc-release: 01 09 2024
medline: 5 10 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

Diagnostic polysomnography (PSG) is the gold standard test to evaluate sleep-disordered breathing in children. Little is known about how children with neurodevelopmental disorders (NDD) tolerate electrodes and sensors in PSG compared to neurotypical children. In this retrospective cohort study of children > 12 months of age who underwent diagnostic PSG at our center from 01/01/2021-30/06/2021, we used sleep technician and physician reports to determine how PSG was tolerated in children with NDD compared to neurotypical children. Subanalyses included tolerance of individual electrodes and sensors and subgroups of NDD (eg, Trisomy 21). A total of 132 children with a NDD and 139 neurotypical children underwent diagnostic PSG. The median age of all children was 8 years, 39% were female, and 50% had a sleep disorder identified on PSG, with no significant differences between NDD and neurotypical groups. The most poorly tolerated sensors for all children were the nasal prongs (poorly tolerated in 30% of all children), followed by thermistor (14%) and electroencephalography electrodes (6%). Children with NDD were > 3 times more likely (odds ratio 3.1, 95% confidence interval 1.8-5.3) to experience problems tolerating any study leads than neurotypical children. Subgroup analysis revealed children with Trisomy 21 had the greatest difficulty tolerating PSG set-up and leads. This retrospective study demonstrates that children with neurodevelopmental disorders are less likely to tolerate PSG monitoring than neurotypical children and highlights the need to develop alternative measures for evaluation of sleep disorders in this population. Lanzlinger D, Kevat A, Collaro A, Poh SH, Pérez WP, Chawla J. Tolerance of polysomnography in children with neurodevelopmental disorders compared to neurotypical peers.

Identifiants

pubmed: 37185049
pii: jcsm.10626
doi: 10.5664/jcsm.10626
pmc: PMC10476030
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1625-1631

Informations de copyright

© 2023 American Academy of Sleep Medicine.

Auteurs

Daniela Lanzlinger (D)

Child Development Service, Children's Health Queensland, Brisbane, Australia.

Ajay Kevat (A)

Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia.
Child Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Andrew Collaro (A)

Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia.

Siew Hui Poh (SH)

Child Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

William Pinzon Pérez (WP)

Queensland Cyber Infrastructure Foundation, The University of Queensland, Brisbane, Australia.

Jasneek Chawla (J)

Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia.
Child Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH